Today: 30 June 2026
DroneShield share price jumps on Defence LAND 156 panel news — what to know before Monday
17 January 2026
1 min read

DroneShield share price jumps on Defence LAND 156 panel news — what to know before Monday

Sydney, Jan 17, 2026, 17:50 AEDT — Market closed

  • DroneShield shares closed Friday 7.8% higher, at A$4.40.
  • The company announced its selection for the Defence Department’s Project LAND 156 LoE 3 standing offer panel, tasked with providing counter-drone services.
  • Investors remain focused on tender activity and upcoming company reporting dates.

DroneShield Ltd shares jumped 7.8% on Friday, closing at A$4.40. The counter-drone specialist revealed it had been chosen for Australia’s Defence Department Project LAND 156 Line of Effort 3 panel. This panel offers Defence a streamlined route to buy counter-drone services for roughly 150 bases and installations through selective tenders, the company noted.

The timing is key as Canberra has marked counter-drone spending a high-priority, fast-moving area. Defence Industry Minister Pat Conroy revealed the government has allocated A$1.3 billion toward counter-drone capabilities across the next decade. That’s why traders are watching closely for any hint procurement might be accelerating, rather than just staying in discussion.

DroneShield announced it has been chosen as a Category 2 provider, allowing Defence to acquire its hardware, software, command-and-control (C2) software, and support services through a “capability as a service” model. The company warned, however, that the panel selection “does not guarantee contracts” and warned sales “cannot be quantified” at this stage, though it expects demand to drive significant business. CEO Oleg Vornik said the firm “welcome[s] the opportunity” to back Defence efforts, while strategy VP Terry Van Haren highlighted a “growing threat from small drones.”

A standing offer panel is basically a list of pre-approved suppliers. It speeds up buying timelines, though each job still goes through separate tenders and evaluations — here, done base by base.

Friday saw the stock swing from A$4.14 up to A$4.46, with roughly 23 million shares traded, per data from Investing.com.

The ASX is closed over the weekend, leaving uncertainty about whether the buying momentum will hold when markets reopen Monday. Deals linked to procurement news often lose steam if investors don’t spot clear next steps.

Traders are focused on any updates about the timing and scope of the tender, looking for clues that the panel is shifting toward real purchase orders. The panel also puts DroneShield in competition with other approved providers whenever Defence issues a limited tender.

The risk is straightforward. Panel selection might appear contractual but may not hold that status, while Defence procurement timelines can drag or pivot as priorities change, even if budgets are set aside.

Looking ahead, investors are eyeing upcoming reporting dates for new figures and guidance. According to MarketIndex’s calendar, DroneShield is set to release its preliminary and annual report on Feb. 24, marking one of the stock’s next key dates.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Telix Pharmaceuticals (ASX:TLX) tops Australian growth stocks with large insider holdings
    June 30, 2026, 3:11 AM EDT. Telix Pharmaceuticals (ASX:TLX) is at the front of Australian growth stocks with high insider ownership, seen as a sign of management confidence. The biopharma group, focused on radiopharmaceuticals in cancer imaging and care, pulled in about US$803.8 million in sales, most of that coming from the U.S. The company's market cap stands at A$5.5 billion. Telix's cancer pipeline is broad, and its commercial footing is firm. Its key products, Illuccix and Gozellix, support 2026 revenue targets of US$950-970 million. There's still risk from regulatory and pricing pressure, but insiders remain aligned, and partnerships with United Imaging and Regeneron support the growth story. Also mentioned: Lindian Resources (ASX:LIN), market cap A$1.7 billion, which is pushing ahead on a rare earths project in Malawi. Both names show that shareholder interest tracks with insider backing.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 17.01.2026

Yangzijiang Shipbuilding share price slid 2.2% to S$3.59 — what to watch before Monday’s SGX open
Next Story

Yangzijiang Shipbuilding share price slid 2.2% to S$3.59 — what to watch before Monday’s SGX open

Go toTop